Le alterazioni elettrocardiografiche espressione di cardiotossicità

Translated title of the contribution: Electrocardiographic changes: Expression of cardiotoxicity

Maria Cristina Lombari, Carlo Gabriele Tocchetti, Carmela Coppola, Angelo Sabato Boccia, Nicola Maurea

Research output: Contribution to journalArticle

Abstract

As the number of drugs and therapeutic strategies for the treatment of cancer continuously increase, early detection and treatment of cardiotoxic side effects are actual and important issue. Along with left ventricular dysfunction, arrhythmic side effects are fairly common. In particular, oncologic patients often present with QT prolongation, since their conditions are associated with concomitant risk factors, such as electrolytic alterations due to dehydration, vomiting or diarrhea, pre-existing cardiovascular diseases, renal or hepathic dysfunctions, other medications which are known for predisposing to QT prolongation.

Original languageItalian
Pages (from-to)55-59
Number of pages5
JournalJournal of Cardiovascular Echography
Volume21
Issue number2
DOIs
Publication statusPublished - 2011

Fingerprint

Preexisting Condition Coverage
Left Ventricular Dysfunction
Dehydration
Vomiting
Diarrhea
Cardiovascular Diseases
Therapeutics
Kidney
Pharmaceutical Preparations
Cardiotoxicity
Neoplasms

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Le alterazioni elettrocardiografiche espressione di cardiotossicità. / Lombari, Maria Cristina; Tocchetti, Carlo Gabriele; Coppola, Carmela; Boccia, Angelo Sabato; Maurea, Nicola.

In: Journal of Cardiovascular Echography, Vol. 21, No. 2, 2011, p. 55-59.

Research output: Contribution to journalArticle

Lombari, Maria Cristina ; Tocchetti, Carlo Gabriele ; Coppola, Carmela ; Boccia, Angelo Sabato ; Maurea, Nicola. / Le alterazioni elettrocardiografiche espressione di cardiotossicità. In: Journal of Cardiovascular Echography. 2011 ; Vol. 21, No. 2. pp. 55-59.
@article{d60c3a85a82d4f8db3a5189927fa65cf,
title = "Le alterazioni elettrocardiografiche espressione di cardiotossicit{\`a}",
abstract = "As the number of drugs and therapeutic strategies for the treatment of cancer continuously increase, early detection and treatment of cardiotoxic side effects are actual and important issue. Along with left ventricular dysfunction, arrhythmic side effects are fairly common. In particular, oncologic patients often present with QT prolongation, since their conditions are associated with concomitant risk factors, such as electrolytic alterations due to dehydration, vomiting or diarrhea, pre-existing cardiovascular diseases, renal or hepathic dysfunctions, other medications which are known for predisposing to QT prolongation.",
keywords = "Antineoplastic treatments, Arrhythmias, Cardiotoxicity, QT prolongation, Target therapy",
author = "Lombari, {Maria Cristina} and Tocchetti, {Carlo Gabriele} and Carmela Coppola and Boccia, {Angelo Sabato} and Nicola Maurea",
year = "2011",
doi = "10.1016/j.jcecho.2011.04.002",
language = "Italian",
volume = "21",
pages = "55--59",
journal = "Journal of Cardiovascular Echography",
issn = "2211-4122",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Le alterazioni elettrocardiografiche espressione di cardiotossicità

AU - Lombari, Maria Cristina

AU - Tocchetti, Carlo Gabriele

AU - Coppola, Carmela

AU - Boccia, Angelo Sabato

AU - Maurea, Nicola

PY - 2011

Y1 - 2011

N2 - As the number of drugs and therapeutic strategies for the treatment of cancer continuously increase, early detection and treatment of cardiotoxic side effects are actual and important issue. Along with left ventricular dysfunction, arrhythmic side effects are fairly common. In particular, oncologic patients often present with QT prolongation, since their conditions are associated with concomitant risk factors, such as electrolytic alterations due to dehydration, vomiting or diarrhea, pre-existing cardiovascular diseases, renal or hepathic dysfunctions, other medications which are known for predisposing to QT prolongation.

AB - As the number of drugs and therapeutic strategies for the treatment of cancer continuously increase, early detection and treatment of cardiotoxic side effects are actual and important issue. Along with left ventricular dysfunction, arrhythmic side effects are fairly common. In particular, oncologic patients often present with QT prolongation, since their conditions are associated with concomitant risk factors, such as electrolytic alterations due to dehydration, vomiting or diarrhea, pre-existing cardiovascular diseases, renal or hepathic dysfunctions, other medications which are known for predisposing to QT prolongation.

KW - Antineoplastic treatments

KW - Arrhythmias

KW - Cardiotoxicity

KW - QT prolongation

KW - Target therapy

UR - http://www.scopus.com/inward/record.url?scp=80052829331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052829331&partnerID=8YFLogxK

U2 - 10.1016/j.jcecho.2011.04.002

DO - 10.1016/j.jcecho.2011.04.002

M3 - Articolo

VL - 21

SP - 55

EP - 59

JO - Journal of Cardiovascular Echography

JF - Journal of Cardiovascular Echography

SN - 2211-4122

IS - 2

ER -